DmitriyBerenzonMD

Oncology • Winston Salem, NC

Assistant Professor, Internal Medicine, Bowman Gray School of Medicine of Wake Forest Univ

Join to view full profile

Dr. Berenzon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Berenzon's full profile

Already have an account?

Office
Medical Center Blvd
Winston Salem, NC 27157
Phone+1 336-716-2255
Is this information wrong?

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2007 - 2010
New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 2004 - 2007
St Petersburg Medical State AcademyClass of 1995

Certifications & Licensure

NY State Medical License 2007 - 2026
NC State Medical License 2010 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders Start of enrollment: 2014 May 01
Completed
Phase 2

Publications & Presentations

PubMed

A Primary Extracutaneous Presentation of Merkel Cell Carcinoma.
Hussain Dalal, Ayesha Iqbal, Pooja Rani, Jamal Saaed, Dmitriy Berenzon> ;Cureus. 2022 Aug 1
34 citations
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
John Mascarenhas, Heidi E Kosiorek, Josef T Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub, Claire N Harrison, Mary Frances McMullin, Alessandro M V...> ;Blood. 2022 May 12
108 citations
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub, John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Dmitriy Berenzon, Maria R. Baer, Ellen K. Ritchie, Richard T. Silver, Craig M. Kessler, Ellio...> ;Blood. 2019 Oct 31
18 citations
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.
John Mascarenhas, Heidi E. Kosiorek, J. T. Prchal, Abdulraheem Yacoub, Dmitriy Berenzon, Maria R. Baer, Ellen K. Ritchie, Richard T. Silver, Craig M. Kessler, Elliot F...> ;Leukemia. 2019 Jul 30
41 citations
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consorti...
Vikas Gupta, Heidi E. Kosiorek, Adam J. Mead, Rebecca B. Klisovic, John P. Galvin, Dmitriy Berenzon, Abdulraheem Yacoub, Auro Viswabandya, Ruben A. Mesa, Judith D. Gol...> ;Biology of Blood and Marrow Transplantation. 2019 Feb 1
47 citations
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.
Raajit K. Rampal, John Mascarenhas, Heidi E. Kosiorek, Leah Price, Dmitriy Berenzon, Elizabeth O. Hexner, Camille N. Abboud, Marina Kremyanskaya, Rona Singer Weinberg,...> ;Blood Advances. 2018 Dec 26
59 citations
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.
Timothy S. Pardee, Rebecca G. Anderson, Kristin M. Pladna, Scott Isom, Lais P. Ghiraldeli, Lance D. Miller, Jeff W. Chou, Guangxu Jin, Wei Zhang, Leslie R. Ellis, Dmit...> ;Clinical Cancer Research. 2018 Feb 6
7 citations
Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit.
Tamjeed Ahmed, Abby L. Koch, Scott Isom, Heidi D. Klepin, Jonathan M. Bishop, Leslie R. Ellis, Dmitriy Berenzon, Dianna S. Howard, Susan Lyerly, Bayard L. Powell, Timo...> ;Leukemia Research. 2017 Nov 1
62 citations
Effect of Intensive Chemotherapy on Physical, Cognitive, and Emotional Health of Older Adults with Acute Myeloid Leukemia.
Heidi D. Klepin, Janet A. Tooze, Timothy S. Pardee, Leslie R. Ellis, Dmitriy Berenzon, Shannon L. Mihalko, Suzanne C. Danhauer, Arati V. Rao, Tanya M. Wildes, Jeff D. ...> ;Journal of the American Geriatrics Society. 2016 Oct 1
21 citations
High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.
Tamjeed Ahmed, Scott Holwerda, Heidi D. Klepin, Scott Isom, Leslie R. Ellis, Susan Lyerly, Megan Manuel, Sarah Dralle, Dmitriy Berenzon, Bayard L. Powell, Timothy S. P...> ;Leukemia Research. 2015 Sep 1
47 citations
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F
Brady L. Stein, Stephen T. Oh, Dmitriy Berenzon, Gabriela S. Hobbs, Marina Kremyanskaya, Raajit K. Rampal, Camille N. Abboud, Kenneth B. Adler, Mark L. Heaney, Elias J...> ;Journal of Clinical Oncology. 2015 Aug 31
13 citations
CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway
Dan Wu, Xinyi Guo, Jing Su, Ruoying Chen, Dmitriy Berenzon, Martin Guthold, Keith Bonin, Weiling Zhao, Xiaobo Zhou> ;Biochimica Et Biophysica Acta. 2015 Feb 1
50 citations
Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML).
Bernard Tawfik, Sarunas Sliesoraitis, Susan Lyerly, Heidi D. Klepin, Julia Lawrence, Scott Isom, Leslie R. Ellis, Megan Manuel, Sarah Dralle, Dmitriy Berenzon, Bayard ...> ;Annals of Hematology. 2014 Jan 1
34 citations
The Survival of Memory CD8 T Cells That Is Mediated by IL-15 Correlates with Sustained Protection Against Malaria
Stasya Zarling, Dmitriy Berenzon, Sarat K. Dalai, Dmitry Liepinsh, Nicholas J. Steers, Urszula Krzych> ;Journal of Immunology. 2013 May 15
Two case reports of MDS with chromosome 7 abnormalities after treatment of AIDS-related Burkitt lymphoma occurring in patients on HAART therapy.
Levitan DA, Lyerly S, Sweet M, Manuel M, Berenzon DP, Pardee TS, Ellis LR, Powell BL> ;J. Clin. Oncol.. 2011-05-20
20 citations
Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells.
Pratima Chaurasia, Dmitriy Berenzon, Ronald Hoffman> ;Blood. 2010 Nov 19
21 citations
Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells
Min Lu, Jiapeng Wang, Yan Li, Dmitriy Berenzon, Xiaoli Wang, John Mascarenhas, Mingjiang Xu, Ronald Hoffman> ;Blood. 2010 Nov 18
63 citations
Interferon-α targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway
Min Lu, Wei Zhang, Yan Li, Dmitriy Berenzon, Xiaoli Wang, Jiapeng Wang, John Mascarenhas, Mingjiang Xu, Ronald Hoffman> ;Experimental Hematology. 2010 Jun 1
The immune status of Kupffer cells profoundly influences their responses to infectious Plasmodium berghei sporozoites.
Steers, N., Schwenk, R., Bacon, D. J., Berenzon, D., Williams, J., Krzych, U.> ;Eur J Immunol. 2005 Aug
Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells.
Berenzon, D., Schwenk, R. J., Letellier, L., Guebre-Xabier, M., Williams, J., Krzych, U.> ;J Immunol. 2003 Aug 15
Join now to see all

Other Languages

Spanish, Russian

Hospital Affiliations

Vassar Brothers Medical CenterPoughkeepsie, New York